Physician

Hanhsing Irene Wu, MD

According to 2025 Medicare claims, Hanhsing Wu, MD (NPI: 1114034832) practices hematology/oncology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 94040-2833. Wu is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Wu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 864 traditional Medicare patients, billed 229,898 HCPCS/CPT codes, and received $4,896,468 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,015 prescription claims across 215 beneficiaries totaling $1,707,429 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2023 DME data shows 46 claims. Open Payments data shows 1 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $895,845 to $4,896,468. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $572,261 to $1,707,429. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.9M2015 Medicare payment: $895,845 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $799,730 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,357,890 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,362,912 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,759,677 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,167,207 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,091,960 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,480,263 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,660,383 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,896,468 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201554863,242$895,845
201652251,748$799,730
201761978,528$1,357,890
201855172,382$1,362,912
2019746162,048$2,759,677
2020632120,848$2,167,207
2021750211,362$4,091,960
2022759190,378$3,480,263
2023753191,040$3,660,383
2024864229,898$4,896,468

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$857K$1.7M2015 Drug cost: $572,261 (USD; Tot_Drug_Cst)2016 Drug cost: $872,546 (USD; Tot_Drug_Cst)2017 Drug cost: $607,262 (USD; Tot_Drug_Cst)2018 Drug cost: $909,195 (USD; Tot_Drug_Cst)2019 Drug cost: $1,338,292 (USD; Tot_Drug_Cst)2020 Drug cost: $1,127,182 (USD; Tot_Drug_Cst)2021 Drug cost: $1,523,122 (USD; Tot_Drug_Cst)2022 Drug cost: $1,714,963 (USD; Tot_Drug_Cst)2023 Drug cost: $1,119,864 (USD; Tot_Drug_Cst)2024 Drug cost: $1,707,429 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015164936$572,261
20161691,141$872,546
2017155939$607,262
2018163894$909,195
2019183998$1,338,292
2020157813$1,127,182
2021170878$1,523,122
2022187816$1,714,963
2023204972$1,119,864
20242151,015$1,707,429

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$37K$74K2015 Medicare payment: $73,580 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $31,576 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $15,576 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,108 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,880 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,887 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,167 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,590 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,492 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201515225$73,580
2016N/R104$31,576
2017N/R67$15,576
20181112$1,108
20191517$1,880
2020N/R25$1,887
2021N/R12$1,167
2022N/R33$1,590
20231146$2,492
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less171508$141
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more186271$111
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less183585$67
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's255366$15
J7050Infusion, normal saline solution, 250 cc264585$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TagrissoOsimertinib Mesylate21630$327,524
VerzenioAbemaciclib12364$204,276
RevlimidLenalidomide14299$165,145
GilotrifAfatinib Dimaleate12360$136,830
AnastrozoleAnastrozole21318,640$4,889

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$31Eisai Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Hanhsing Irene Wu, MD?

Tedicare shows public-source Medicare data for Hanhsing Irene Wu, MD (NPI 1114034832), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hanhsing Irene Wu, MD have ACO affiliation data?

Hanhsing Irene Wu, MD is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Hanhsing Irene Wu, MD?

Hanhsing Irene Wu, MD is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Hanhsing Irene Wu, MD have Open Payments data?

Hanhsing Irene Wu, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.